Successful 5G mmWave trial demonstrates extended range capabilities to deliver faster speeds and broader coverage for residential customers
Dubai, UAE, March 5, 2026: du, the leading telecom and digital services provider, and Ericsson (NASDAQ: ERIC) have successfully completed a proof of concept (PoC) deploying 5G Standalone (SA) using millimeter wave (mmWave) extended range technology in residential areas across the UAE.
Increase in memberships signals strong investor confidence
2,709 new member companies joined Dubai Chamber of Commerce in March 2026
H.E. Mohammad Ali Rashed Lootah:
“Dubai’s economic model rests on a strong foundation that combines resilience, proactive planning, effective public-private collaboration, and deep ties with global markets.”
“The growing number of companies joining the chamber during March is a clear signal that Dubai’s investment momentum remains strong and that the emirate continues to inspire confidence among the global business community.”
Opening Its Full Infrastructure to Homegrown GCC BrandsDubai-born brand introduces acceleration program that opens its retail stores, 50,000-customer database, warehouse, AI tools, office space, partner network, influencer relationships, distribution, and developer and marketing teams to homegrown brands across the GCC – using AI to match every brand with exactly what they need.
April, Dubai, UAE – The world is going through difficult times. Across the GCC, homegrown brands with genuine potential are struggling – not because their products aren’t good enough, but because they don’t have the platform to prove it.
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
Dubai, April 3, 2026 – Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association’s annual conference in San Diego showing that Wegovy® (semaglutide) tablets 25 mg was associated with significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison. It is important to note that the FDA recently approved orforglipron under the brand name Foundayo™ at doses ranging up to 17.2 mg. The approved 17.2 mg tablet is the equivalent to the orforglipron 36 mg capsules used in Phase 3 trials, and which served as the study comparator in ORION. Additionally, in a separate patient preference study, adults with overweight or obesity showed greater preference for an oral semaglutide–like profile than an orforglipron-like profile.1,2 These findings suggest potential differentiation and provide valuable insights to inform clinical decision-making.
• Engaged 738,785 students across national and international platforms • Diverted 1,744,328 kg of waste from landfills • Mitigated 6006.77 metric tonnes of carbon dioxide • Saved 11,215 cubic metres of landfill space • Planted 14,301 native and Mangrove trees in 2025
Dubai, UAE – 26 March 2026: The Emirates Environmental Group (EEG) hosted its 29th Annual Corporate Gala Dinner, a distinguished evening dedicated to recognising sustainability leadership, strengthening partnerships and reaffirming the UAE’s steadfast commitment to environmental progress. Held under the gracious patronage of His Highness Engr. Sheikh Salim Bin Sultan Bin Saqr Al Qasimi, Chairman of Ras Al Khaimah Civil Aviation and Member of the Executive Council of the Government of Ras Al Khaimah, the event convened high-level dignitaries, members of the diplomatic corps, corporate executives, policymakers and sustainability advocates from across the region.
UAE News 24/7 